Geospiza Acquires Award-Winning GeneSifter® Data Analysis Product
News Nov 21, 2008
Geospiza, Inc. and VizX Labs have announced a definitive agreement whereby Geospiza has acquired the GeneSifter Data Analysis product.
Geospiza expects that this product will provide scientists a true sample to results solution for gene expression for both microarrays and next generation sequencing.
“Our goal is to make it easier for our customers to manage and analyze the unprecedented amount of data required for genetic analysis today. GeneSifter is a key addition to the toolset we provide to accomplish that,” said Rob Arnold, president of Geospiza.
“The integration of GeneSifter will accelerate expansion of our data analysis capabilities and address the scientific community’s need for data management and analysis across multiple platforms. GeneSifter will expand our market by addressing the demand for sophisticated data analysis across microarray, capillary electrophoresis and next generation sequencing platforms.”
John Thompson, CEO of VizX Labs, said, “We are thrilled to join Geospiza. The Geospiza product development team is exceptional and will increase the breadth and depth of our offerings to GeneSifter customers. We have always recognized the value in extending our data analysis capabilities to new platforms to accelerate discovery. This step reflects our commitment to that goal.”
Technical integration between GeneSifter and Geospiza’s FinchLab product promises to be seamless.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019
4th Annual Congress on Nanomedicine and Drug Delivery
Apr 04 - Apr 06, 2019